A synthetic peptide for use as a blocking control in assays to test for specificity of SLC29 A2 antibody, Alternative Names: SLC29A2 control peptide, SLC29A2 antibody Blocking Peptide, Anti-SLC29A2 Blocking Peptide, Solute Carrier Family 29 Member 2 Blocking Peptide, Nucleoside Transporters 2 Blocking Peptide, DER12 Blocking Peptide, ENT2 Blocking Peptide, HNP36 Blocking Peptide, SLC29A2, SLCA2-29, SLCA2 29, SLCA2-29 Blocking Peptide, SLCA2 29 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
SLC29A2
(Solute Carrier Family 29 (Nucleoside Transporters), Member 2 (SLC29A2))
Hintergrund
SLC29A2 mediates equilibrative transport of purine, pyrimidine nucleosides and the purine base hypoxanthine. It is less sensitive than SLC29A1 to inhibition by nitrobenzylthioinosine (NBMPR), dipyridamole, dilazep and draflazine.